Internal Medicine, Rheumatology · Modesto, CA
NPI
1386718971
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4601 Dale Rd
Modesto, CA, 95356
Phone (209) 557-1000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.0M
2,330 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Win M Lim prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 434 prescriptions and refills. In total Win M Lim wrote 2,330 Medicare prescriptions that cost $2.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 434 | 1,183 | 163 | $8,671 |
| Prednisone Generic | 395 | 743 | 159 | $3,586 |
| Hydroxychloroquine Sulfate Generic | 229 | 656 | 92 | $7,194 |
| Leflunomide Generic | 201 | 635 | 94 | $6,546 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 121 | 139 | 23 | $136K |
| Xeljanz Tofacitinib Citrate | 115 | 115 | 20 | $329K |
| Enbrel Sureclick Etanercept | 112 | 112 | 16 | $554K |
| Meloxicam Generic | 78 | 171 | 38 | $614 |
| Amjevita(Cf) Adalimumab-Atto | 47 | 57 | Under 11 | $50K |
| Mycophenolate Mofetil Generic | 45 | 122 | 18 | $6,581 |
| Otezla Apremilast | 44 | 44 | Under 11 | $195K |
| Enbrel Etanercept | 44 | 44 | Under 11 | $218K |
| Sulfasalazine Generic | 43 | 118 | 20 | $2,862 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 36 | 36 | Under 11 | $90K |
| Ibuprofen Generic | 28 | 37 | 13 | $433 |
Brand drugs: 695 claims; generic drugs: 1,613 claims; opioid claims: 11.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Win M Lim were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.